CD274 and neoplasm: The EMT signaling upregulates the immune checkpoint molecule PD1 ligand (PDL1, CD274) expression in tumor cells dependent on the PI3K/AKT and MEK/ERK pathways, and PDL1 functionally regulates EMT through the RAS/ERK pathway [24,25].